Atlas Trials

Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

Clinical trial NCT06952517 · RECRUITING

Trial details

NCT number
NCT06952517
Sponsor
Narrows Institute for Biomedical Research
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Papular-pustular RosaceaPapulopustular Rosacea (PPR)Papulopustular Rosacea
Start date
2025-03-14
Primary completion
2025-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.